JOIN PHARMA
0846.679.346 · rovalta.com · 25/09/2026
JOIN PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOJOIN PHARMA is a Private limited company incorporated in 2012. Its main activity is: Activities of holding companies. Its registered office is in Tervuren.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0846.679.346
- Incorporation
- 18/06/2012
- Legal form
- Private limited company
- Registered office
- Lindenberg 16
3080 Tervuren · FlandreSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 21,5 k € | +42.3% | 15,1 k € | +367% | 3,2 k € | -72.5% | 11,7 k € | -6.1% | 12,5 k € |
| EBITDA | 20,5 k € | +35.7% | 15,1 k € | +386% | 3,1 k € | -71.7% | 10,9 k € | -11.4% | 12,3 k € |
| Operating result | 20,3 k € | +34.7% | 15,1 k € | +399% | 3 k € | -71.9% | 10,7 k € | -6.9% | 11,5 k € |
| Net result | 41,3 k € | +45.4% | 28,4 k € | -48.7% | 55,4 k € | +6.3% | 52,1 k € | +15.0% | 45,4 k € |
| Balance sheet | |||||||||
| Equity | 569,1 k € | +7.8% | 527,8 k € | +3.9% | 508,2 k € | +10.1% | 461,6 k € | +10.9% | 416,2 k € |
| Total assets | 1,2 M € | +4.7% | 1,1 M € | +1.7% | 1,1 M € | +4.5% | 1 M € | +1.8% | 1 M € |
| Cash | 21,1 k € | +127% | 9,3 k € | -87.5% | 74,1 k € | +6.5% | 69,6 k € | -3.3% | 71,9 k € |
| Debts | 599 k € | +1.9% | 587,6 k € | -0.2% | 588,7 k € | +0.2% | 587,7 k € | -4.4% | 614,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Other companies at this address
Lindenberg 16 3080 Tervuren| Company | CBE no. |
|---|---|
E & A FARMA● Active | 0477.349.371 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 29/06/2026 | 30/06/2025 | 05/07/2024 | 05/07/2023 | 30/07/2022 | 28/07/2021 |
| General meeting | 26/06/2026 | 27/06/2025 | 28/06/2024 | 30/06/2023 | 30/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 26/06/2026 | 29/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 27/06/2025 | 30/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/06/2024 | 05/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 05/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 30/06/2022 | 30/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 25/06/2021 | 28/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 26/06/2020 | 03/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 28/06/2019 | 08/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 29/06/2018 | 24/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 20/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 24/06/2016 | 18/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 26/06/2015 | 30/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 27/06/2014 | 14/07/2014 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202541,3 k €↑
- 2024Annual accounts 202428,4 k €↓
- 2023Annual accounts 202355,4 k €↑
- 2022Annual accounts 202252,1 k €↑
- 2021Annual accounts 202145,4 k €↑
- 2020Annual accounts 202036,6 k €↑
- 2019Annual accounts 201910,3 k €↑
- 2018Annual accounts 201810,2 k €↑
- 2017Annual accounts 20178,8 k €↓
- 2016Annual accounts 201637,4 k €↓
- 2015Annual accounts 2015446,8 k €↑
- 2014Annual accounts 201412,6 k €↓
- 2013Annual accounts 201350,1 k €
- 18/06/2012IncorporationPrivate limited company